Skip to content
Search

Latest Stories

EU to borrow $8.5 billion to boost spending on vaccines, drugs

THE European Commission on Wednesday (27) proposed borrowing €7.7 billion ($8.49 billion) on financial markets to fund extra spending on vaccines, drugs and healthcare over the next four years and reduce its dependency on foreign supplies.

The plan, which requires approval from EU member governments and lawmakers, would complement a $2.6 billion emergency fund which could also be deployed to address medical shortages in the bloc highlighted by the COVID-19 pandemic.


"Europe should strive to strengthen its strategic autonomy by reducing excessive import dependence for the most-needed goods and services such as medical products and pharmaceuticals," an EU document published on Wednesday said.

Under the proposal, the Commission would use the EU's €1.1-trillion-long-term budget as a guarantee to borrow €750 billion, of which €7.7 billion would be used for medical expenses until the end of 2024.

Another €1.7 billion would be made available for health spending directly from the EU budget until 2027.

The Commission, the EU's executive arm, said the aim of the overall package would be ensuring strategic supplies of drugs and medical equipment, helping the development and production of vaccines in the EU, and strengthening the 27-nation bloc's preparedness and prevention of future health crises.

The Commission did not provide a breakdown of medical expenditures, but stressed the need to address "vulnerabilities" that emerged during the COVID-19 outbreak.

These included temporary shortages of crucial medicines, partly due to disruptions in supplies of chemical ingredients in drugs, for which the EU relies on China and India for 80 per cent of its needs.

The crisis has also exposed the EU's limited vaccine production capacity, which may leave the bloc with a shortage of COVID-19 shots if they became available.

Under the €7.7 billion plan, for which more details are expected on Thursday (28), Brussels would also offer "incentives" to the pharmaceutical industry to relocate production of vaccines and essential drugs to the EU.

More For You

Prudential to list Indian asset management venture

Prudential chief executive Anil Wadhwani

Prudential to list Indian asset management venture

INSURER Prudential plc announced that it is considering a partial listing of its stake in ICICI Prudential Asset Management, one of India's leading investment firms. The news sent Prudential's shares soaring by 5.8 per cent to close at 722p on the London Stock Exchange.

The FTSE 100 company currently holds a 49 per cent stake in the Indian joint venture, which market analysts estimate to be worth around £4 billion. ICICI Bank, which owns the remaining 51 per cent, has confirmed its intention to maintain its majority shareholding, emphasising its "long-term commitment" to the partnership that began in 1998, reported the Times.

Keep ReadingShow less
NatWest-Reuters

The bank has set a new performance target, aiming for a return on tangible equity of 15-16 per cent in 2025 and above 15 per cent by 2027. (Photo: Reuters)

What’s driving NatWest’s better-than-expected profit growth?

NATWEST reported higher-than-expected annual profit on Friday, supported by its growth strategy, improved productivity, and capital management efforts.

The bank, which once had assets worth 2.2 trillion pounds—more than twice the size of the British economy—has undergone years of restructuring to focus mainly on domestic consumer and mortgage lending.

Keep ReadingShow less
London business district
A general view shows the London's financial district from an office window in Canary Wharf. (Photo: Getty Images)

Economy grows 0.1 per cent in fourth quarter, defying expectations

THE UK economy expanded by 0.1 per cent in the final quarter of 2024, contrary to forecasts of a contraction, according to official data released on Thursday.

The growth, supported by a stronger-than-expected 0.4 per cent rise in December, offers some relief to chancellor Rachel Reeves as she navigates broader economic challenges.

Keep ReadingShow less
BP-Reuters

Fourth-quarter profit dropped 61 per cent compared to the previous year, marking BP’s weakest results since Q4 2020, when the pandemic reduced global oil demand. (Photo: Reuters)

BP reports lowest quarterly profit in four years, plans strategy reset

BP reported a quarterly profit of £943 million on Tuesday, falling short of expectations and marking its lowest in four years.

The company said it plans a "fundamental reset" of its strategy, days after reports that Elliott Management had taken a stake in the oil major.

Keep ReadingShow less
Shein-Reuters

Shein had aimed to go public in London in the first half of this year, subject to regulatory approvals in the UK and China. (Photo: Reuters)

Shein cuts valuation to £40 billion for London listing

SHEIN is preparing to lower its valuation to around £40 billion for a potential initial public offering (IPO) in London, according to three Reuters sources familiar with the matter.

This is nearly 25 per cent lower than the company's 2023 fundraising valuation as it faces increasing challenges.

Keep ReadingShow less